MUFG Securities EMEA plc raised its stake in HCA Healthcare, Inc. (NYSE:HCA – Free Report) by 108.9% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 6,548 shares of the company’s stock after buying an additional 3,413 shares during the period. MUFG Securities EMEA plc’s holdings in HCA Healthcare were worth $3,057,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors also recently made changes to their positions in the business. Norges Bank acquired a new position in shares of HCA Healthcare in the 4th quarter valued at about $1,262,513,000. Eurizon Capital SGR S.p.A. acquired a new position in shares of HCA Healthcare in the 4th quarter valued at about $31,801,000. Hillsdale Investment Management Inc. acquired a new position in shares of HCA Healthcare in the 4th quarter valued at about $976,000. Triglav Investments D.O.O. lifted its stake in shares of HCA Healthcare by 7.4% in the 4th quarter. Triglav Investments D.O.O. now owns 2,148 shares of the company’s stock valued at $1,003,000 after purchasing an additional 148 shares during the period. Finally, Fideuram Asset Management Ireland dac acquired a new position in shares of HCA Healthcare in the 4th quarter valued at about $1,551,000. 62.73% of the stock is owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
A number of brokerages recently commented on HCA. Leerink Partners decreased their target price on HCA Healthcare from $573.00 to $500.00 and set an “outperform” rating for the company in a research report on Monday, April 27th. Sanford C. Bernstein decreased their target price on HCA Healthcare from $541.00 to $503.00 and set a “market perform” rating for the company in a research report on Tuesday, April 28th. Stephens decreased their target price on HCA Healthcare from $560.00 to $530.00 and set an “overweight” rating for the company in a research report on Monday, April 27th. Barclays decreased their target price on HCA Healthcare from $551.00 to $496.00 and set an “overweight” rating for the company in a research report on Monday, April 27th. Finally, Wall Street Zen lowered HCA Healthcare from a “buy” rating to a “hold” rating in a research report on Saturday, May 2nd. Sixteen investment analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $515.77.
HCA Healthcare Price Performance
HCA opened at $370.77 on Tuesday. The company has a market capitalization of $82.25 billion, a price-to-earnings ratio of 12.75, a P/E/G ratio of 1.20 and a beta of 1.12. The firm’s fifty day moving average price is $449.37 and its two-hundred day moving average price is $480.24. HCA Healthcare, Inc. has a 1 year low of $330.00 and a 1 year high of $556.52.
HCA Healthcare (NYSE:HCA – Get Free Report) last released its earnings results on Friday, April 24th. The company reported $7.15 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.19 by ($0.04). The business had revenue of $19.11 billion during the quarter, compared to the consensus estimate of $19.09 billion. HCA Healthcare had a net margin of 8.89% and a negative return on equity of 295.93%. The business’s revenue was up 4.3% on a year-over-year basis. During the same period in the prior year, the company earned $6.45 earnings per share. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. As a group, equities analysts anticipate that HCA Healthcare, Inc. will post 30.07 EPS for the current year.
HCA Healthcare Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, June 30th. Stockholders of record on Tuesday, June 16th will be issued a $0.78 dividend. The ex-dividend date of this dividend is Tuesday, June 16th. This represents a $3.12 annualized dividend and a dividend yield of 0.8%. HCA Healthcare’s dividend payout ratio is currently 10.73%.
About HCA Healthcare
HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.
The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.
Read More
- Five stocks we like better than HCA Healthcare
- Why These Three Big Buybacks Are Sending Very Different Signals to Investors
- Drone Stocks Soar As Pentagon Considers Funding, Including a Trump-Linked Name
- Braze Blazes Ahead on Q1 2027 Earnings Beat, Raised Guidance
- Are the 3 Newest Members of the $1 Trillion Market Cap Club the Latest Sign of an AI Bubble?
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA – Free Report).
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
-logo-1200x675.png){kind=logo}